Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moiety
- 17 March 2019
- journal article
- research article
- Published by Elsevier BV in European Journal of Medicinal Chemistry
- Vol. 171, 180-194
- https://doi.org/10.1016/j.ejmech.2019.03.027
Abstract
No abstract availableKeywords
Funding Information
- National Science Centre (2014/13/D/NZ7/00322, 2016/23/N/NZ7/00351)
This publication has 50 references indexed in Scilit:
- Investigation of the Biological Properties of (Hetero)Aromatic ThiosemicarbazonesMolecules, 2012
- Regulation of Ribonucleotide Reductase in Response to Iron DeficiencyMolecular Cell, 2011
- Anticancer Activity of Metal Complexes: Involvement of Redox ProcessesAntioxidants and Redox Signaling, 2011
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic CancerMolecular Pharmacology, 2011
- Modulation of gene expression in U251 glioblastoma cells by binding of mutant p53 R273H to intronic and intergenic sequencesNucleic Acids Research, 2009
- A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreasInvestigational New Drugs, 2008
- Structure–Activity Relationships of Novel Iron Chelators for the Treatment of Iron Overload Disease: The Methyl Pyrazinylketone Isonicotinoyl Hydrazone SeriesJournal of Medicinal Chemistry, 2007
- Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor AgentsJournal of Medicinal Chemistry, 2007
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences, 2006
- The Action of Nine Chelators on Iron-Dependent Radical DamageFree Radical Research, 1994